Levocetirizine Dihydrochloride Ennogen Healthcare

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Dihydrochloride Ennogen Healthcare, is a second‑generation antihistamine presented as an oral dosage form for oral use. It is used to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children when appropriate. GNH USA supplies Levocetirizine Dihydrochloride Ennogen Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine Dihydrochloride is a selective H1‑receptor antagonist that alleviates allergic conditions by blocking peripheral histamine activity. - Allergic rhinitis: reduces nasal congestion, sneezing, and itching. - Chronic idiopathic urticaria: diminishes wheal formation and itching. - Allergic conjunctivitis: eases eye redness, tearing, and irritation.

Levocetirizine Dihydrochloride is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Drowsiness: mild to moderate sleepiness. - Headache: transient cranial discomfort. - Dry mouth: reduced salivation. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, or throat. - Anaphylaxis: severe, life‑threatening allergic reaction. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before using Levocetirizine Dihydrochloride, consider the following safety points. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: weigh potential benefits against risks to the infant. - Renal impairment: dose adjustment may be required in reduced kidney function. - Elderly patients: monitor for increased sedation or confusion. - Driving or operating machinery: avoid if drowsiness occurs. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levocetirizine Dihydrochloride can interact with other substances that affect the central nervous system or drug metabolism.

Major Interactions (Avoid): - Alcohol: may enhance sedative effects. - CNS depressants (e.g., benzodiazepines): additive drowsiness. - Ritonavir: can increase levocetirizine plasma concentrations.

Moderate Interactions (Monitor Closely): - Theophylline: levocetirizine may raise theophylline levels. - Ketoconazole: may elevate levocetirizine exposure. - Anticholinergic agents: may worsen dry mouth.